Novartis Investigative Site

Basingstoke RG24 9NA

0 studies enrolling now · 3 studies all time

What they study most

Carcinoid Tumor, Malignant Carcinoid Syndrome, Obesity, Overweight, Symptomatic Refractory Resistant Carcinoid Disease

Studies at this site

• A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults — Completed
• Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor — Completed
• Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease — Completed